Singapore markets closed

Easywell Biomedicals, Inc. (1799.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
130.00+11.50 (+9.70%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
308,079
271,628
178,897
197,277
267,654
Cost of revenue
111,301
100,910
102,583
146,847
183,693
Gross profit
196,778
170,718
76,314
50,430
83,961
Operating expenses
Research development
283,830
271,499
209,411
238,143
221,610
Selling general and administrative
80,491
61,957
28,161
24,149
21,211
Total operating expenses
364,321
333,456
237,572
262,292
242,821
Operating income or loss
-167,543
-162,738
-161,258
-211,862
-158,860
Interest expense
19,960
19,258
17,246
16,082
16,073
Income before tax
-172,915
-169,909
-168,275
-169,660
-182,819
Income tax expense
322
256
119
849
2,027
Income from continuing operations
-173,237
-170,165
-168,394
-170,509
-184,846
Net income
-144,278
-144,818
-161,000
-150,391
-173,412
Net income available to common shareholders
-144,278
-144,818
-161,000
-150,391
-173,412
Basic EPS
-1.27
-1.26
-1.39
-1.44
-1.84
Diluted EPS
-1.27
-1.26
-1.39
-1.44
-1.84
Basic average shares
115,624
115,681
115,624
104,123
94,294
Diluted average shares
115,624
115,681
115,624
104,123
94,294